Drug intelligence / Profile preview

autologous bone marrow-derived stem cells (LifeStem)

Development stage
Unknown
Lead developer
LifeStem
Modality
Stem Cell Therapies → Cell Therapies
Administration
Testicular Injection
01

Overview

LifeStem's autologous stem cell therapy is an experimental regenerative medicine approach designed to treat non-obstructive azoospermia, a condition where sperm production is severely impaired or absent. The therapy involves the extraction of adult stem cells from the patient's own bone marrow, which are then processed and delivered via direct testicular injection into the seminiferous tubules or interstitial spaces. The primary objective is to restore spermatogenesis by allowing the transplanted autologous stem cells to differentiate into functional germ cells within the testicular microenvironment. This treatment aims to address male infertility by leveraging the regenerative potential of bone marrow-derived stem cells to repopulate the germ cell niche and potentially restore fertility.

Other names
Autologous Stem Cells - Testicular InjectionLifeStem azoospermia cell therapy

Beyond the preview

Go deeper on autologous bone marrow-derived stem cells (LifeStem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived stem cells (LifeStem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call